Comments
Loading...
Erasca (NASDAQ:ERAS) Stock Quotes, Forecast and News Summary
Erasca Stock (NASDAQ: ERAS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Erasca (ERAS) stock?
You can purchase shares of Erasca (NASDAQ:ERAS) through any online brokerage.
Who are Erasca (ERAS) competitors?
Other companies in Erasca’s space includes: Humacyte (NASDAQ:HUMA), Upstream Bio (NASDAQ:UPB), Celcuity (NASDAQ:CELC), Altimmune (NASDAQ:ALT) and PureTech Health (NASDAQ:PRTC).
What is the forecast, or price target, for Erasca (ERAS) stock?
Erasca has a consensus price target of $7.69.
What is the current price for Erasca (ERAS)?
The stock price for Erasca (NASDAQ: ERAS) is $1.455 last updated February 26, 2025 at 12:29 PM EST.
Does Erasca (ERAS) pay a dividend?
There are no upcoming dividends for Erasca.
When is Erasca (NASDAQ:ERAS) reporting earnings?
Erasca’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Erasca (ERAS) going to split?
There is no upcoming split for Erasca.
What sector and industry does Erasca (ERAS) operate in?
Erasca is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.